Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMB19IO)

Drug Name
Ad-IL-12 DNA therapeutic Drug Info
Synonyms INXN-2001
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1/2 [1]
Recurrent glioblastoma 2A00.00 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMB19IO

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-12 beta (IL12B) TTGW72V IL12B_HUMAN Modulator [3]

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

ICD Disease Classification 02 Neoplasm
Disease Class ICD-11: 2C82 Prostate cancer
The Studied Tissue Skin
The Studied Disease Melanoma [ICD-11:2C82]
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interleukin-12 beta (IL12B) DTT IL12B 1.08E-01 0.13 0.17
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Clinical pipeline report, company report or official report of ZIOPHARM.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 National Cancer Institute Drug Dictionary (drug id 710508).